Abstract：Objective: To explore the application effect of Xueshuantong capsule combined with Conbercept in patients with central retinal vein occlusion (CRVO) and macular oedema. Methods: A total of 90 patients with ischemic CRVO and macular oedema were enrolled between October 2019 and September 2021. According to simple random grouping method, they were divided into group A (45 cases, 45 eyes, Conbercept combined with Xueshuantong capsules) and group B (45 cases, 45 eyes, Conbercept). All were treated for 3 months. The onset time of visual acuity, retinal circulation time, central macular thickness (CMT), fundus hemodynamics, best corrected visual acuity (BCVA), serum indexes and adverse reactions in the two groups were compared. Results: The response rate of treatment in the two groups was similar (χ2=0.179, P>0.05). Compared with group B, onset time of visual acuity was shorter in group A (t=2.237, P<0.05). After treatment, retinal circulation time was similar in the two groups (t=1.149, P>0.05). After 2 and 3 months of treatment, CMT was thinner in group A than group B (t=3.884, 2.104, P<0.05). Compared with group B after treatment, increments of peak systolic velocity and end-diastolic velocity were greater in group A, while decrements of resistance index and pulsatility index were greater in group A (t=7.240, 6.452, 6.202, 6.442, P<0.05). After 1 month of treatment, BCVA log MAR was lower in group A than group B (t=2.472, P<0.05). Compared with group B after treatment, increment of serum nitric oxide synthetase was greater in group A, while decrements of interleukin-6 and vascular endothelial growth factor were greater in group A (t=7.799, 15.034, 4.973, P<0.05). The incidence of adverse reactions was similar in the two groups (P>0.05). Conclusion: Compared with Conbercept alone, Conbercept combined with Xueshuantong capsule is conducive to the relief of macular edema, improvement of retinal microcirculation, and vision recovery in CRVO.
唐会超, 李满, 王冬梅, 周玉, 陈宝兴. 血栓通胶囊联合康柏西普治疗在视网膜中央静脉阻塞合并黄斑水肿患者中的应用研究[J]. 河北医学, 2023, 29(9): 1569-1574.
TANG Huichao, LI Man, WANG Dongmei, et al. Application of Xueshuantong Capsule Combined with Conbercept in Patients with Central Retinal Vein Occlusion and Macular Oedema. HeBei Med, 2023, 29(9): 1569-1574.
2023, Vol. 29 
冀公网安备13080202000677号